Replication Data for: FliW2 A Potential Therapeutic Target for Helicobacter pylori

NIAID Data Ecosystem2026-05-02 收录

幽门螺杆菌药物

FliW2蛋白功能

数据链接：

https://doi.org/10.7910/DVN/YC6D3H 数据链接链接失效反馈

官方服务：

资源简介：

The dataset includes the original and supplementary data involved in the paper.

创建时间：

2024-05-24

In Vitro and In Vivo Activities of Tea Catechins against Helicobacter pylori

幽门螺杆菌药物

茶多酚研究

The catechin epigallocatechin gallate showed the strongest activity of the six tea catechins tested against Helicobacter pylori (MIC for 50% of the strains tested, 8 μg/ml). It had bactericidal activi

PubMed Central40

Structure of Helicobacter Pylori peptide deformylase in complex with inhibitor

幽门螺杆菌药物

蛋白质结构解析

Structure of Helicobacter Pylori peptide deformylase in complex with inhibitor Descriptor: (2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE, COBALT (II) ION, peptide deformylase Aut

Protein Data Bank Japan2023-10-25 更新30

Purine nucleoside phosphorylase(DeoD-type) from H. pylori with 6-benzyloxo-2-chloropurine

蛋白酶-抑制剂复合物结构

幽门螺杆菌药物

Purine nucleoside phosphorylase(DeoD-type) from H. pylori with 6-benzyloxo-2-chloropurine Descriptor: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, 6-benzyloxo-2-chloropurine, GLYCEROL, ... Authors: Narcz

Protein Data Bank Japan2024-11-20 更新20

North America Drugs For Helicobacter Pylori Infections Market

幽门螺杆菌药物

医药市场分析

Technological advancements in the North America Drugs For Helicobacter Pylori Infections industry are shaping the future market landscape. The report evaluates innovation-driven growth and how emergin

IMR REPORTS40

The order of the study’s synthesized primers.

幽门螺杆菌药物

体外药效学

The primary treatment method for eradicating Helicobacter pylori (H. pylori) infection involves the use of antibiotic-based therapies. Due to the growing antibiotic resistance of H. pylori, there has

Figshare2024-04-11 更新20

Replication Data for: FliW2 A Potential Therapeutic Target for Helicobacter pylori

资源简介：

相关数据集